These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6135925)

  • 1. Targeting coronary risk factor control.
    Oliver MF
    Lancet; 1983 Aug; 2(8347):449-50. PubMed ID: 6135925
    [No Abstract]   [Full Text] [Related]  

  • 2. Trials of coronary heart disease prevention.
    Lancet; 1982 Oct; 2(8302):803-4. PubMed ID: 6126668
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy and clinical trials.
    Dutta-Roy AK
    Curr Opin Lipidol; 1999 Feb; 10(1):81-3. PubMed ID: 10095996
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trials of cholesterol lowering for the secondary prevention of coronary heart disease].
    Koizumi J
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():252-6. PubMed ID: 17821900
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting coronary risk factor control.
    Lancet; 1983 Jul; 2(8343):213-14. PubMed ID: 6135041
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid lowering drugs and coronary heart disease.
    Scott PJ
    Drugs; 1975; 10(3):218-25. PubMed ID: 1104340
    [No Abstract]   [Full Text] [Related]  

  • 7. Which changes in diet prevent coronary heart disease? A review of clinical trials of dietary fats and antioxidants.
    Oliver MF
    Acta Cardiol; 1996; 51(6):467-90. PubMed ID: 9124017
    [No Abstract]   [Full Text] [Related]  

  • 8. Marine n-3 polyunsaturated fatty acids and coronary heart disease: Part II. clinical trials and recommendations.
    Schmidt EB; Arnesen H; Christensen JH; Rasmussen LH; Kristensen SD; De Caterina R
    Thromb Res; 2005; 115(4):257-62. PubMed ID: 15668184
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of coronary heart disease by diet.
    Leren P
    Postgrad Med J; 1975; 51(8):44-6. PubMed ID: 768946
    [No Abstract]   [Full Text] [Related]  

  • 10. Fish, marine n-3 polyunsaturated fatty acids and coronary heart disease: a minireview with focus on clinical trial data.
    Schmidt EB; Rasmussen LH; Rasmussen JG; Joensen AM; Madsen MB; Christensen JH
    Prostaglandins Leukot Essent Fatty Acids; 2006 Sep; 75(3):191-5. PubMed ID: 16844362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Prudence" in disease prevention.
    Froom J; Froom P
    J Clin Epidemiol; 1991; 44(11):1127-30. PubMed ID: 1941007
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of coronary heart disease through cholesterol reduction.
    Grundy SM
    Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-3 fatty acids and the primary prevention of coronary artery disease.
    Dubnov G; Berry EM
    Isr Med Assoc J; 2004 Aug; 6(8):507-8; author reply 508. PubMed ID: 15326841
    [No Abstract]   [Full Text] [Related]  

  • 14. The Multiple Risk Factor Intervention Trial: quality control of technical procedures and data acquisition. Multiple Risk Factor Intervention Trial Research Group.
    Control Clin Trials; 1986 Sep; 7(3 Suppl):1S-202S. PubMed ID: 3802836
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality control procedures for the resting electrocardiogram in the Multiple Risk Factor Intervention Trial.
    Rautaharju PM; Broste SK; Prineas RJ; Eifler WJ; Crow RS; Furberg CD
    Control Clin Trials; 1986 Sep; 7(3 Suppl):46S-65S. PubMed ID: 3802846
    [No Abstract]   [Full Text] [Related]  

  • 16. Mass control of coronary risk factors.
    Lancet; 1983 Aug; 2(8346):406-7. PubMed ID: 6135903
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality control site visits to clinics in the Multiple Risk Factor Intervention Trial.
    Kirkpatrick K; Johnson P; Morgan J; Lamb S
    Control Clin Trials; 1986 Sep; 7(3 Suppl):126S-36S. PubMed ID: 3802838
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in the treatment of coronary heart disease: fish oils, cholestyramine, and mevinolin.
    Stacpoole PW; Alig J
    Cardiovasc Clin; 1987; 18(1):267-79. PubMed ID: 3300984
    [No Abstract]   [Full Text] [Related]  

  • 19. Mortality and the multiple risk factor intervention trial.
    Stallones RA
    Am J Epidemiol; 1983 Jun; 117(6):647-50. PubMed ID: 6344618
    [No Abstract]   [Full Text] [Related]  

  • 20. Multifactorial primary prevention trials of coronary heart disease.
    Farchi G
    Rev Epidemiol Sante Publique; 1984; 32(3-4):219-24. PubMed ID: 6395228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.